Related references
Note: Only part of the references are listed.Salidroside Attenuates LPS-Induced Acute Lung Injury in Rats
Liu Jingyan et al.
INFLAMMATION (2017)
Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways
Yi-Song Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Impact of family history of metabolic traits on severity of non-alcoholic steatohepatitis related cirrhosis: A cross-sectional study
Ajeet S. Bhadoria et al.
LIVER INTERNATIONAL (2017)
HMGB1, an innate alarmin, plays a critical role in chronic inflammation of adipose tissue in obesity
Jing Zhang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients
Elizandra Silva Guimaraes et al.
CARDIOVASCULAR THERAPEUTICS (2017)
被撤回的出版物: Salidroside alleviates cigarette smoke-induced COPD in mice (Retracted article. See vol. 160, 2023)
Fen Luo et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease?
Arianna Mazzotti et al.
DIGESTIVE AND LIVER DISEASE (2017)
AGEs and HMGB1 Increase Inflammatory Cytokine Production from Human Placental Cells, Resulting in an Enhancement of Monocyte Migration
Koumei Shirasuna et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2016)
Abrogation of Toll-like receptor 4 (TLR4) mitigates obesity-induced insulin resistance and glucose intolerance through reducing mitochondrial ROS in visceral fat
Hung-Yu Lin et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2016)
Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes
Yongxin Sun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Salidroside suppresses inflammation in a D-galactose-induced rat model of Alzheimer's disease via SIRT1/NF-κB pathway
Jin Gao et al.
METABOLIC BRAIN DISEASE (2016)
Catalpol ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by suppressing the JNK and NF-κB pathways
Jun Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
Jessica Bazick et al.
DIABETES CARE (2015)
HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2
Yue Liang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Plasma HMGB-1 Levels in Subjects with Obesity and Type 2 Diabetes: A Cross-Sectional Study in China
Hang Wang et al.
PLOS ONE (2015)
The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus
G. Daniele et al.
ACTA DIABETOLOGICA (2014)
Inhibition of inflammasome activation improves the impaired pattern of healing in genetically diabetic mice
Alessandra Bitto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
Julio C. Tobon-Velasco et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells
R. Guzman-Ruiz et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
Domenica Musumeci et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant?
Vishwa Deep Dixit
DIABETES (2013)
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Hye-Mi Lee et al.
DIABETES (2013)
Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation
Michelle E. Heid et al.
JOURNAL OF IMMUNOLOGY (2013)
The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis
Huan Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan et al.
NATURE MEDICINE (2013)
Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
Ryan W. Grant et al.
FRONTIERS IN IMMUNOLOGY (2013)
Atorvastatin reduces serum HMGB1 levels in patients with hyperlipidemia
Daoqun Jin et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
Yun-Hee Youm et al.
ENDOCRINOLOGY (2011)
HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
Jose Augusto Nogueira-Machado et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Adipose and Liver Expression of Interleukin (IL)-1 Family Members in Morbid Obesity and Effects of Weight Loss
Alexander R. Moschen et al.
MOLECULAR MEDICINE (2011)
Low Dose Organochlorine Pesticides and Polychlorinated Biphenyls Predict Obesity, Dyslipidemia, and Insulin Resistance among People Free of Diabetes
Duk-Hee Lee et al.
PLOS ONE (2011)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Kate Schroder et al.
SCIENCE (2010)
Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes
Frederico G. S. Toledo et al.
DIABETES CARE (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways
C González-Yanes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Share Paper
